1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5.
Global
Vendor-Neutral Archive (VNA) and PACS Market Outlook
5.1. Market Size & Forecast
5.1.1.
By Value
5.2. Market Share & Forecast
5.2.1. By Imaging Modality (Angiography,
Mammography, Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Others)
5.2.2. By Type (PACS,
VNA Software)
5.2.3. By Mode
of Delivery (On-Site, Hybrid, Cloud-hosted)
5.2.4. By Usage
Model (Single Department, Multiple Departments, Multiple Sites)
5.2.5. By
Region
5.2.6.
By Company (2023)
5.3. Market Map
5.3.1.
By Imaging Modality
5.3.2.
By Type
5.3.3.
By Mode of Delivery
5.3.4.
By Usage Model
5.3.5.
By Region
6.
North America Vendor-Neutral
Archive (VNA) and PACS Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1.
By Imaging Modality
(Angiography, Mammography, Computed Tomography, Magnetic Resonance Imaging,
Ultrasound, Others)
6.2.2.
By Type (PACS, VNA
Software)
6.2.3.
By Mode of Delivery
(On-Site, Hybrid, Cloud-hosted)
6.2.4.
By Usage Model
(Single Department, Multiple Departments, Multiple Sites)
6.2.5.
By Country
6.3. North America: Country Analysis
6.3.1.
United States Vendor-Neutral
Archive (VNA) and PACS Market Outlook
6.3.1.1.
Market Size &
Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share &
Forecast
6.3.1.2.1.
By Imaging Modality
6.3.1.2.2.
By Type
6.3.1.2.3.
By Mode of Delivery
6.3.1.2.4.
By Usage Model
6.3.2.
Canada Vendor-Neutral
Archive (VNA) and PACS Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share &
Forecast
6.3.2.2.1.
By Imaging Modality
6.3.2.2.2.
By Type
6.3.2.2.3.
By Mode of Delivery
6.3.2.2.4.
By Usage Model
6.3.3.
Mexico Vendor-Neutral
Archive (VNA) and PACS Market Outlook
6.3.3.1.
Market Size &
Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share &
Forecast
6.3.3.2.1.
By Imaging Modality
6.3.3.2.2.
By Type
6.3.3.2.3.
By Mode of Delivery
6.3.3.2.4.
By Usage Model
7.
Europe Vendor-Neutral
Archive (VNA) and PACS Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1.
By Imaging Modality
(Angiography, Mammography, Computed Tomography, Magnetic Resonance Imaging, Ultrasound,
Others)
7.2.2.
By Type (PACS, VNA
Software)
7.2.3.
By Mode of Delivery
(On-Site, Hybrid, Cloud-hosted)
7.2.4.
By Usage Model
(Single Department, Multiple Departments, Multiple Sites)
7.2.5.
By Country
7.3. Europe: Country Analysis
7.3.1.
Germany Vendor-Neutral
Archive (VNA) and PACS Market Outlook
7.3.1.1.
Market Size &
Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share &
Forecast
7.3.1.2.1.
By Imaging Modality
7.3.1.2.2.
By Type
7.3.1.2.3.
By Mode of Delivery
7.3.1.2.4.
By Usage Model
7.3.2.
United Kingdom Vendor-Neutral
Archive (VNA) and PACS Market Outlook
7.3.2.1.
Market Size &
Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share &
Forecast
7.3.2.2.1.
By Imaging Modality
7.3.2.2.2.
By Type
7.3.2.2.3.
By Mode of Delivery
7.3.2.2.4.
By Usage Model
7.3.3.
France Vendor-Neutral
Archive (VNA) and PACS Market Outlook
7.3.3.1.
Market Size &
Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share &
Forecast
7.3.3.2.1.
By Imaging Modality
7.3.3.2.2.
By Type
7.3.3.2.3.
By Mode of Delivery
7.3.3.2.4.
By Usage Model
7.3.4.
Italy Vendor-Neutral
Archive (VNA) and PACS Market Outlook
7.3.4.1.
Market Size &
Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share &
Forecast
7.3.4.2.1.
By Imaging Modality
7.3.4.2.2.
By Type
7.3.4.2.3.
By Mode of Delivery
7.3.4.2.4.
By Usage Model
7.3.5.
Spain Vendor-Neutral
Archive (VNA) and PACS Market Outlook
7.3.5.1.
Market Size &
Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share &
Forecast
7.3.5.2.1.
By Imaging Modality
7.3.5.2.2.
By Type
7.3.5.2.3.
By Mode of Delivery
7.3.5.2.4.
By Usage Model
8.
Asia-Pacific Vendor-Neutral
Archive (VNA) and PACS Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
By Imaging Modality
(Angiography, Mammography, Computed Tomography, Magnetic Resonance Imaging,
Ultrasound, Others)
8.2.2.
By Type (PACS, VNA Software)
8.2.3.
By Mode of Delivery
(On-Site, Hybrid, Cloud-hosted)
8.2.4.
By Usage Model
(Single Department, Multiple Departments, Multiple Sites)
8.2.5.
By Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China Vendor-Neutral
Archive (VNA) and PACS Market Outlook
8.3.1.1.
Market Size &
Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share &
Forecast
8.3.1.2.1.
By Imaging Modality
8.3.1.2.2.
By Type
8.3.1.2.3.
By Mode of Delivery
8.3.1.2.4.
By Usage Model
8.3.2.
Japan Vendor-Neutral
Archive (VNA) and PACS Market Outlook
8.3.2.1.
Market Size &
Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share &
Forecast
8.3.2.2.1.
By Imaging Modality
8.3.2.2.2.
By Type
8.3.2.2.3.
By Mode of Delivery
8.3.2.2.4.
By Usage Model
8.3.3.
India Vendor-Neutral
Archive (VNA) and PACS Market Outlook
8.3.3.1.
Market Size &
Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share &
Forecast
8.3.3.2.1.
By Imaging Modality
8.3.3.2.2.
By Type
8.3.3.2.3.
By Mode of Delivery
8.3.3.2.4.
By Usage Model
8.3.4.
Australia Vendor-Neutral
Archive (VNA) and PACS Market Outlook
8.3.4.1.
Market Size &
Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share &
Forecast
8.3.4.2.1.
By Imaging Modality
8.3.4.2.2.
By Type
8.3.4.2.3.
By Mode of Delivery
8.3.4.2.4.
By Usage Model
8.3.5.
South Korea Vendor-Neutral
Archive (VNA) and PACS Market Outlook
8.3.5.1.
Market Size &
Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share &
Forecast
8.3.5.2.1.
By Imaging Modality
8.3.5.2.2.
By Type
8.3.5.2.3.
By Mode of Delivery
8.3.5.2.4.
By Usage Model
9.
South America Vendor-Neutral
Archive (VNA) and PACS Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
By Imaging Modality (Angiography,
Mammography, Computed Tomography, Magnetic Resonance Imaging, Ultrasound,
Others)
9.2.2.
By Type (PACS, VNA
Software)
9.2.3.
By Mode of Delivery
(On-Site, Hybrid, Cloud-hosted)
9.2.4.
By Usage Model
(Single Department, Multiple Departments, Multiple Sites)
9.2.5.
By Country
9.3. South America: Country Analysis
9.3.1.
Brazil Vendor-Neutral
Archive (VNA) and PACS Market Outlook
9.3.1.1.
Market Size &
Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share &
Forecast
9.3.1.2.1.
By Imaging Modality
9.3.1.2.2.
By Type
9.3.1.2.3.
By Mode of Delivery
9.3.1.2.4.
By Usage Model
9.3.2.
Argentina Vendor-Neutral
Archive (VNA) and PACS Market Outlook
9.3.2.1.
Market Size &
Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share &
Forecast
9.3.2.2.1.
By Imaging Modality
9.3.2.2.2.
By Type
9.3.2.2.3.
By Mode of Delivery
9.3.2.2.4.
By Usage Model
9.3.3.
Colombia Vendor-Neutral
Archive (VNA) and PACS Market Outlook
9.3.3.1.
Market Size &
Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share &
Forecast
9.3.3.2.1.
By Imaging Modality
9.3.3.2.2.
By Type
9.3.3.2.3.
By Mode of Delivery
9.3.3.2.4.
By Usage Model
10.
Middle East and
Africa Vendor-Neutral Archive (VNA) and PACS Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Imaging Modality (Angiography, Mammography,
Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Others)
10.2.2. By Type (PACS, VNA Software)
10.2.3. By Mode of Delivery (On-Site, Hybrid,
Cloud-hosted)
10.2.4. By Usage Model (Single Department, Multiple
Departments, Multiple Sites)
10.2.5. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Vendor-Neutral Archive (VNA) and
PACS Market Outlook
10.3.1.1.
Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share &
Forecast
10.3.1.2.1.
By Imaging Modality
10.3.1.2.2.
By Type
10.3.1.2.3.
By Mode of Delivery
10.3.1.2.4.
By Usage Model
10.3.2. Saudi Arabia Vendor-Neutral Archive (VNA) and
PACS Market Outlook
10.3.2.1.
Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share &
Forecast
10.3.2.2.1.
By Imaging Modality
10.3.2.2.2.
By Type
10.3.2.2.3.
By Mode of Delivery
10.3.2.2.4.
By Usage Model
10.3.3. UAE Vendor-Neutral Archive (VNA) and PACS Market Outlook
10.3.3.1.
Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share &
Forecast
10.3.3.2.1.
By Imaging Modality
10.3.3.2.2.
By Type
10.3.3.2.3.
By Mode of Delivery
10.3.3.2.4.
By Usage Model
10.3.4. Kuwait Vendor-Neutral Archive (VNA) and PACS Market Outlook
10.3.4.1.
Market Size &
Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share &
Forecast
10.3.4.2.1.
By Imaging Modality
10.3.4.2.2.
By Type
10.3.4.2.3.
By Mode of Delivery
10.3.4.2.4.
By Usage Model
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Porter’s Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New
Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Products
14. Competitive Landscape
14.1. Agfa HealthCare NV
14.1.1.
Business Overview
14.1.2.
Products & Services
14.1.3.
Recent Developments
14.1.4.
Financials (As Reported)
14.1.5.
Key Personnel
14.1.6.
SWOT Analysis
14.2. Dell Technologies
Inc
14.3. FUJIFILM Holdings
Corp
14.4. GE Healthcare Inc
14.5. International
Business Machines Corp
14.6. Koninklijke Philips
NV
14.7. Lexmark
International Inc
14.8. McKesson Corp
14.9. Novarad Corp
14.10. Siemens Healthineers AG
15. Strategic Recommendations
16.
About Us & Disclaimer